Inhibitor

(redirected from angiogenesis inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.
Related to angiogenesis inhibitor: tumor angiogenesis

inhibitor

[in′hib·əd·ər]
(aerospace engineering)
A substance bonded, taped, or dip-dried onto a solid propellant to restrict the burning surface and to give direction to the burning process.
(chemistry)
A substance which is capable of stopping or retarding a chemical reaction; to be technically useful, it must be effective in low concentration.

Inhibitor

 

a circuit having m + n inputs and a single output, at which a signal can appear only when there are no signals on the m inputs (inhibiting). The other n inputs (principal) form one of the two logic connections, “AND” or “OR.” Inhibitors are used extensively in computers. They are very often understood to be a circuit having a single principal input and a single inhibiting input. A signal appears at the output of such a circuit when a signal is present on the principal input but there is none on the inhibiting input. Such an inhibitor is called an anticoincidence gate; its conventional representation is given in Figure 1.

Figure 1. Block diagram of an anticoincidence gate (inhibitor) with m — 1 and n 1:(A) principal input, (Q) inhibiting input, (Ga) anticoincidence gate

inhibitor

A substance added to paint to retard drying, skinning, mildew growth, etc. Also see corrosion inhibitor, inhibiting pigment, drying inhibitor.
References in periodicals archive ?
But new research suggests certain angiogenesis inhibitors may actually promote the growth of tumours.
Moulton stated that she will explore several key areas in her EntreMed-sponsored research efforts over the next two years: "With regard to plaque neovascularization, or new blood vessel growth, research efforts will focus on gaining an understanding of the role angiogenesis inhibitors play in the delay of plaque progression.
Decision Resources' new Emerging Markets Physician & Payer Forum report entitled Emerging Markets Physician & Payer Forum: Payer and Clinician Perspectives on the Role of Premium-Priced Angiogenesis Inhibitors in Brazil and Mexico also finds that--in line with interviewed payer insights--surveyed prescribers of Roche/Genentech/Chugai's Avastin in Brazil and Mexico identify patients with good performance status as prime candidates for Avastin treatment, along with younger patients and those without comorbidities.
In 2009, angiogenesis inhibitors captured more than three-quarters of the renal cell carcinoma drug market, with Pfizer's Sutent accounting for 61 percent of sales in this class," said Decision Resources Analyst Karen Pomeranz, Ph.
According to the report, the angiogenesis inhibitor drug class will continue to dominate this market over the next decade, capturing 87 percent of total sales in 2018.
PI-88 is a compound that is unique among other angiogenesis inhibitors, and we are looking forward to investigating its potential in treating cancer patients," Dr.
Table 6: World Historic Review for Angiogenesis Inhibitors &
Rupnick and her colleagues have ruled out the possibility that angiogenesis inhibitors simply made the mice sick or spoiled their taste for food.
Table 24: US Historic Review for Angiogenesis Inhibitors &
The prostate cancer market is reaching maturity, and major players' sales have been eroded by the launch of various LHRH agonist depot formulations, we identify that angiogenesis inhibitors will be the most promising for future treatment of prostate cancer.
Angiogenesis stimulants last only a short time, whereas the angiogenesis inhibitors seem to work for months, at least in mice.